share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144：擬議出售證券

美股sec公告 ·  02/21 23:20
牛牛AI助理已提取核心訊息
Vertex Pharmaceuticals Inc. officer, David Altshuler, is set to sell 3,002 common shares of the company on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Altshuler over the past three months, totaling 7,147 shares for gross proceeds of $3,005,656.38.
Vertex Pharmaceuticals Inc. officer, David Altshuler, is set to sell 3,002 common shares of the company on 02/21/2024, with an aggregate market value of $1,266,153.54. The shares were acquired on 02/20/2024 as performance shares, a form of compensation from the issuer. This transaction follows a recent history of sales by Altshuler over the past three months, totaling 7,147 shares for gross proceeds of $3,005,656.38.
Vertex Pharmicals Inc.高管戴維·阿爾特舒勒定於2024年2月21日出售該公司的3,002股普通股，總市值爲1,266,153.54美元。這些股票於2024年2月20日作爲績效股票收購，這是發行人的一種補償形式。該交易遵循了Altshuler在過去三個月中的近期銷售記錄，共計7,147股股票，總收益爲3,005,656.38美元。
Vertex Pharmicals Inc.高管戴維·阿爾特舒勒定於2024年2月21日出售該公司的3,002股普通股，總市值爲1,266,153.54美元。這些股票於2024年2月20日作爲績效股票收購，這是發行人的一種補償形式。該交易遵循了Altshuler在過去三個月中的近期銷售記錄，共計7,147股股票，總收益爲3,005,656.38美元。
有用
沒用

該公告為獨立文件：

獨立文件1

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。